Literature DB >> 23078194

Long-term child follow-up after large obstetric randomised controlled trials for the evaluation of perinatal interventions: a systematic review of the literature.

M J Teune1, A G van Wassenaer, G L Malin, E Asztalos, Z Alfirevic, B W J Mol, B C Opmeer.   

Abstract

BACKGROUND: Although the hope is that many perinatal interventions are performed with an ultimate aim to improve the long-term health and development of the child, long-term outcome is rarely used as a primary end-point in perinatal randomised controlled trials (RCTs).
OBJECTIVE: To evaluate how often and with which tools long-term follow-up is performed after large obstetric RCTs. SEARCH STRATEGY: We searched the Cochrane Library for Cochrane reviews published by the Cochrane Pregnancy and Childbirth Group for reviews on interventions that aimed to improve neonatal outcome. Selection criteria  Reviews on perinatal interventions that were not performed to improve the condition of the neonate were excluded. We limited our review to RCTs with more than 350 participating women. For each included study, we checked in Web of Science as to whether the researchers had reported on follow-up in subsequent publications. DATA COLLECTION AND ANALYSIS: Relevant information was extracted from these RCTs by two reviewers using a predefined data collection sheet. All information was analysed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA). MAIN
RESULTS: We studied 212 reviews including 1837 RCTs on perinatal interventions, 249 (14%) of which included 350 participants. Only 40 of 249 RCTs (16%) followed the children after discharge from the hospital to evaluate the effect of a specific perinatal intervention. The number of RCTs with long-term follow-up remained stable, with 10 of 67 RCTs (15%) reporting follow-up before 1990, 17 of 115 (15%) between 1990 and 2000, and 13 of 67 (19%) after 2000 (P = 0.68).
CONCLUSIONS: Only a small minority of large perinatal RCTs report the long-term follow-up of the child. Future obstetric RCTs should consider performing long-term follow-up at the start of the trial.
© 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG.

Entities:  

Mesh:

Year:  2012        PMID: 23078194     DOI: 10.1111/j.1471-0528.2012.03465.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  12 in total

Review 1.  Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus.

Authors:  Joanna Tieu; Emily Shepherd; Philippa Middleton; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2017-01-03

Review 2.  Clinical pharmacology in neonates: small size, huge variability.

Authors:  Karel Allegaert; John N van den Anker
Journal:  Neonatology       Date:  2014-05-30       Impact factor: 4.035

3.  Infant outcome at four years of age after intrapartum sampling of scalp blood lactate for fetal assessment. A cohort study.

Authors:  Nana Wiberg; Tobias Wirenfeldt Klausen; Tobias Tyrberg; Lennart Nordström; Eva Wiberg-Itzel
Journal:  PLoS One       Date:  2018-03-23       Impact factor: 3.240

4.  Effects of tocolysis with nifedipine or atosiban on child outcome: follow-up of the APOSTEL III trial.

Authors:  Tms van Winden; J Klumper; C E Kleinrouweler; M A Tichelaar; C A Naaktgeboren; T A Nijman; A L van Baar; A G van Wassenaer-Leemhuis; T J Roseboom; J Van't Hooft; C Roos; B W Mol; E Pajkrt; M A Oudijk
Journal:  BJOG       Date:  2020-03-29       Impact factor: 6.531

5.  Child outcomes after placement of a cervical pessary in women with a multiple pregnancy: A 4-year follow-up of the ProTWIN trial.

Authors:  Noor E Simons; Cornelieke van de Beek; Johanna H van der Lee; Brent C Opmeer; Aleid G van Wassenaer-Leemhuis; Anneloes L van Baar; Leonie Steenis; Sophie Liem; Ewoud Schuit; Dick Bekedam; Ben W J Mol; Janneke Van't Hooft
Journal:  Acta Obstet Gynecol Scand       Date:  2019-06-18       Impact factor: 3.636

6.  Study protocol for a randomized trial on timely delivery versus expectant management in late preterm small for gestational age pregnancies with an abnormal umbilicocerebral ratio (UCR): the DRIGITAT study.

Authors:  M Smies; S E Damhuis; R G Duijnhoven; A G Leemhuis; S J Gordijn; W Ganzevoort
Journal:  Trials       Date:  2022-08-01       Impact factor: 2.728

7.  Which factors play a role in the decision of mothers to participate in child follow-up examinations after participation in an RCT?: a semi-quantitative study.

Authors:  Tamara den Harink; Annemieke Hoek; Henk Groen; Tessa J Roseboom; Arend van Deutekom
Journal:  BMJ Open       Date:  2022-08-18       Impact factor: 3.006

8.  A Core Outcome Set for Evaluation of Interventions to Prevent Preterm Birth.

Authors:  Janneke van 't Hooft; James M N Duffy; Mandy Daly; Paula R Williamson; Shireen Meher; Elizabeth Thom; George R Saade; Zarko Alfirevic; Ben Willem J Mol; Khalid S Khan
Journal:  Obstet Gynecol       Date:  2016-01       Impact factor: 7.661

9.  Progesterone for prevention of preterm birth in women with short cervical length: 2-year infant outcomes.

Authors:  C J J Cuijpers; J Van't Hooft; C Schneeberger; J H Van Der Lee; N E Simons; M A Van Os; J Van Der Ven; C J M De Groot; B W J Mol; A G Van Wassenaer-Leemhuis
Journal:  Ultrasound Obstet Gynecol       Date:  2021-02-12       Impact factor: 7.299

10.  Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial.

Authors:  Anadeijda J E M C Landman; Marjon A de Boer; Laura Visser; Tobias A J Nijman; Marieke A C Hemels; Christiana N Naaktgeboren; Marijke C van der Weide; Ben W Mol; Judith O E H van Laar; Dimitri N M Papatsonis; Mireille N Bekker; Joris van Drongelen; Mariëlle G van Pampus; Marieke Sueters; David P van der Ham; J Marko Sikkema; Joost J Zwart; Anjoke J M Huisjes; Marloes E van Huizen; Gunilla Kleiverda; Janine Boon; Maureen T M Franssen; Wietske Hermes; Harry Visser; Christianne J M de Groot; Martijn A Oudijk
Journal:  PLoS Med       Date:  2022-02-01       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.